NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice. 2017

Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR 97239.

Global distribution of hepatocellular carcinomas (HCCs) is dominated by its incidence in developing countries, accounting for >700,000 estimated deaths per year, with dietary exposures to aflatoxin (AFB1) and subsequent DNA adduct formation being a significant driver. Genetic variants that increase individual susceptibility to AFB1-induced HCCs are poorly understood. Herein, it is shown that the DNA base excision repair (BER) enzyme, DNA glycosylase NEIL1, efficiently recognizes and excises the highly mutagenic imidazole ring-opened AFB1-deoxyguanosine adduct (AFB1-Fapy-dG). Consistent with this in vitro result, newborn mice injected with AFB1 show significant increases in the levels of AFB1-Fapy-dG in Neil1 vs. wild-type liver DNA. Further, Neil1 mice are highly susceptible to AFB1-induced HCCs relative to WT controls, with both the frequency and average size of hepatocellular carcinomas being elevated in Neil1 The magnitude of this effect in Neil1 mice is greater than that previously measured in Xeroderma pigmentosum complementation group A (XPA) mice that are deficient in nucleotide excision repair (NER). Given that several human polymorphic variants of NEIL1 are catalytically inactive for their DNA glycosylase activity, these deficiencies may increase susceptibility to AFB1-associated HCCs.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011042 Poisons Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) Poison
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D000348 Aflatoxins Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2. Aflatoxin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D045647 DNA Glycosylases A family of DNA repair enzymes that recognize damaged nucleotide bases and remove them by hydrolyzing the N-glycosidic bond that attaches them to the sugar backbone of the DNA molecule. The process called BASE EXCISION REPAIR can be completed by a DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE which excises the remaining RIBOSE sugar from the DNA. DNA N-glycosidase,DNA Glycosylase,Methylpurine DNA Glycosylase,DNA Glycosylase, Methylpurine,DNA N glycosidase,Glycosylase, DNA,Glycosylase, Methylpurine DNA,Glycosylases, DNA
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
January 2022, Chemico-biological interactions,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
September 2021, Scientific reports,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
August 1993, Cancer research,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
September 1980, Tropical and geographical medicine,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
May 2024, Journal of traditional and complementary medicine,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
September 1985, Toxicology letters,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
August 2023, Journal of fungi (Basel, Switzerland),
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
November 2019, Journal of cellular and molecular medicine,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
November 2005, Cancer biology & therapy,
Vladimir Vartanian, and Irina G Minko, and Supawadee Chawanthayatham, and Patricia A Egner, and Ying-Chih Lin, and Lauriel F Earley, and Rosemary Makar, and Jennifer R Eng, and Matthew T Camp, and Liang Li, and Michael P Stone, and Michael R Lasarev, and John D Groopman, and Robert G Croy, and John M Essigmann, and Amanda K McCullough, and R Stephen Lloyd
December 1984, Lancet (London, England),
Copied contents to your clipboard!